Treatment Effects on Neuromuscular Properties on Young Women Symptomatic for Patellofemoral Pain Syndrome
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03663595 |
|
Recruitment Status :
Completed
First Posted : September 10, 2018
Last Update Posted : February 14, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Patellofemoral Pain Syndrome | Other: Model 1 Other: Model 2 | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 86 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Effects of Two Treatment Models on Neuromuscular Properties of Young Women Symptomatic for Patellofemoral Pain Syndrome: A Randomized Controlled Trial |
| Actual Study Start Date : | August 9, 2018 |
| Actual Primary Completion Date : | December 20, 2019 |
| Actual Study Completion Date : | July 30, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
No Intervention: Control Group
Females asymptomatic for patellofemoral pain syndrome
|
|
|
Experimental: PFPS: Proximal factors - Model 1 (Hip and Knee)
Females symptomatic for PFPS with modification in proximal factors related to patellofemoral pain. This group will be submitted to the rehabilitation program with exercises focusing in proximal (hip) and local (knee) factors.
|
Other: Model 1
Model 1 will be composed of exercises focusing on local (knee) and proximal (hip) factors.
Other Name: Local and proximal factors |
|
Experimental: PFPS: Proximal factors - Model 2 (knee, foot and ankle)
Females symptomatic for PFPS with modification in proximal factors related to patellofemoral pain. This group will be submitted to the rehabilitation program with exercises focusing in distal (foot and ankle) and local (knee) factors.
|
Other: Model 2
Model 2 will be composed of exercises focused on the local (knee) and distal (ankle and foot) factors.
Other Name: Local and distal factors |
|
Experimental: PFPS: Distal factors - Model 1(Hip and Knee)
Females symptomatic for PFPS with modification in distal factors related to patellofemoral pain. This group will be submitted to the rehabilitation program with exercises focusing in proximal (hip) and local (knee) factors.
|
Other: Model 1
Model 1 will be composed of exercises focusing on local (knee) and proximal (hip) factors.
Other Name: Local and proximal factors |
|
Experimental: AKP: Distal factors - Model 2 (knee, foot and ankle)
Females symptomatic for PFPS with modification in distal factors related to patellofemoral pain. This group will be submitted to the rehabilitation program with exercises focusing in local (knee) and distal (foot and ankle) factors.
|
Other: Model 2
Model 2 will be composed of exercises focused on the local (knee) and distal (ankle and foot) factors.
Other Name: Local and distal factors |
- Change in knee muscles, hip muscles, ankle muscles and foot muscles strength (measured by joint torque, obtained by dynamometry). [ Time Frame: The evaluation will be performed to baseline (pre-intervention), change from baseline to 6 weeks of intervention and change from baseline to 12 weeks of intervention. ]Torque is an expression of the muscular strength and was assessed by dynamometry
- Change of knee muscles, hip muscles, ankle muscles and foot muscles architecture [ Time Frame: The evaluation will be performed to baseline (pre-intervention), change from baseline to 6 weeks of intervention and change from baseline to 12 weeks of intervention. ]Muscular architecture (muscle thickness, pennation angle and fascicle length) will be assessed by ultrasonography
- CChange of knee muscles, hip muscles, ankle muscles and foot muscles electrical activation [ Time Frame: The evaluation will be performed to baseline (pre-intervention), change from baseline to 6 weeks of intervention and change from baseline to 12 weeks of intervention. ]Electrical activation will be assessed by surface electromyography (EMG)
- Change of patellofemoral cartilage thickness [ Time Frame: The evaluation will be performed to baseline (pre-intervention), change from baseline to 6 weeks of intervention and change from baseline to 12 weeks of intervention. ]Patellofemoral cartilage thickness will be assessed by ultrasonography
- Change of kinematic of pelvis, hip, knee and ankle during single leg squat [ Time Frame: The evaluation will be performed to baseline (pre-intervention), change from baseline to 6 weeks of intervention and change from baseline to 12 weeks of intervention. ]Single leg squat will be measured with a video camera, and will be used to determine lower limb functionality
- Change of kinematic of pelvis, hip, knee and ankle during drop landing test [ Time Frame: The evaluation will be performed to baseline (pre-intervention), change from baseline to 6 weeks of intervention and change from baseline to 12 weeks of intervention. ]Drop landing will be measured with a video camera, and will be used to determine lower limb functionality
- Change of knee pain through Visual Analogue Scale [ Time Frame: The evaluation will be performed to baseline (pre-intervention), change from baseline to 6 weeks of intervention and change from baseline to 12 weeks of intervention. ]Knee pain will be measured with a Visual Analogue Scale (0-100mm), where 0 and 100 mm corresponded to no discomfort and worst perceived discomfort, respectively.
- Change of Navicular Drop test [ Time Frame: The evaluation will be performed to baseline (pre-intervention), change from baseline to 6 weeks of intervention and change from baseline to 12 weeks of intervention. ]Navicular drop height (standing and siting) will be measured with a photograph obtained at the sagittal plane
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 40 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Patellofemoral pain syndrome group:
Inclusion Criteria:
- Peripatellar or retropatellar pain in at least two of the following situations:
squatting, running, kneeling, jumping, climbing or descending stairs and sitting for a prolonged period of time for at least three months
Exclusion Criteria:
- Engaged in systematic exercise with focus on lower limb in the last six months and Had an injury to the hip and ankle joint in the last 12 months
Control group: Healthy subjects assymptomatic for patellofemoral pain and no injury to the hip and ankle joint in the last 12 months
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03663595
| Brazil | |
| Exercise Research Laboratory, School of Physical Education, Federal University of Rio Grande do Sul | |
| Porto Alegre, Rio Grande Do Sul, Brazil, 90690-200 | |
| Principal Investigator: | Marco Vaz, PhD | Federal University of Rio Grande do Sul |
| Responsible Party: | Marco Aurélio Vaz, PhD, Principal Investigator, Federal University of Rio Grande do Sul |
| ClinicalTrials.gov Identifier: | NCT03663595 |
| Other Study ID Numbers: |
UFRGS - 2.809.328 |
| First Posted: | September 10, 2018 Key Record Dates |
| Last Update Posted: | February 14, 2022 |
| Last Verified: | February 2022 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Patellofemoral pain Etiology Multiarticular rehabilitation Local factors Nonlocal factors |
|
Patellofemoral Pain Syndrome Syndrome Somatoform Disorders Disease |
Pathologic Processes Mental Disorders Joint Diseases Musculoskeletal Diseases |

